CD274 and endometrial cancer: For instance, estrogen has been identified as a regulator for the immune microenvironment of liver metastasis36; meanwhile, Schalper et found estradiol (E2) to increase programmed death ligand (PD-L1) expression in breast and endometrial cancer; hence, allowing cancer to escape immunosurveillance37.